Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-07-22 4:18 pm Purchase | 13G | Terns Pharmaceuticals Inc. TERN | CITADEL ADVISORS LLC | 3,410,764 5.3% | 3,410,764![]() (New Position) | View |
2024-07-22 4:11 pm Purchase | 13G | Sphere Entertainment Co. SPHR | CITADEL ADVISORS LLC | 1,506,957 5.3% | 1,506,957![]() (New Position) | View |
2024-04-25 5:51 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC. MRNS | CITADEL ADVISORS LLC | 222,335 0.4% | 222,335![]() (New Position) | View |
2024-04-22 4:05 pm Purchase | 13G | Protara Therapeutics Inc. TARA | CITADEL ADVISORS LLC | 1,213,132 5.7% | 1,213,132![]() (New Position) | View |
2024-03-25 4:12 pm Purchase | 13G | REV Group Inc. REVG | CITADEL ADVISORS LLC | 2,697,273 5.2% | 2,697,273![]() (New Position) | View |
2024-03-22 4:43 pm Purchase | 13G | CUMMINS INC CMI | CITADEL ADVISORS LLC | 263,557 0.2% | 263,557![]() (New Position) | View |
2024-03-18 4:13 pm Purchase | 13G | ATARA BIOTHERAPEUTICS INC ATRA | CITADEL ADVISORS LLC | 6,533,119 6.4% | 6,533,119![]() (New Position) | View |
2024-02-23 4:01 pm Purchase | 13G | HELIX ACQUISITION CORP II HLXB | CITADEL ADVISORS LLC | 1,322,155 7% | 1,322,155![]() (New Position) | View |
2024-02-14 6:18 pm Purchase | 13G | Lyra Therapeutics Inc. LYRA | CITADEL ADVISORS LLC | 4,286,927 7.9% | 1,390,392![]() (+48.00%) | View |
2024-02-14 6:18 pm Sale | 13G | Jasper Therapeutics Inc. JSPR | CITADEL ADVISORS LLC | 230,620 0.2% | -3,498,450![]() (-93.82%) | View |
2024-02-14 6:18 pm Sale | 13G | Harpoon Therapeutics Inc. HARP | CITADEL ADVISORS LLC | 1,027,956 6% | -3![]() (-0.00%) | View |
2024-02-14 6:18 pm Sale | 13G | Blink Charging Co. BLNK | CITADEL ADVISORS LLC | 426,857 0.6% | -1,967,591![]() (-82.17%) | View |
2024-02-14 6:18 pm Purchase | 13G | Vistagen Therapeutics Inc. VTGN | CITADEL ADVISORS LLC | 1,600,768 5.8% | 6,832![]() (+0.43%) | View |
2024-02-14 6:18 pm Sale | 13G | Groupon Inc. GRPN | CITADEL ADVISORS LLC | 1,273,880 4% | -70,624![]() (-5.25%) | View |
2024-02-14 6:18 pm Purchase | 13G | ALLURION TECHNOLOGIES INC. ALUR | CITADEL ADVISORS LLC | 2,563,726 5.1% | 6,609![]() (+0.26%) | View |
2024-02-14 6:18 pm Purchase | 13G | Intuitive Machines Inc. LUNR | CITADEL ADVISORS LLC | 843,505 3.9% | 843,505![]() (New Position) | View |
2024-02-14 6:18 pm Sale | 13G | Appreciate Holdings Inc. SFRT | CITADEL ADVISORS LLC | 965,611 5.4% | -154,481![]() (-13.79%) | View |
2024-02-14 6:18 pm Purchase | 13G | ACELYRIN Inc. SLRN | CITADEL ADVISORS LLC | 6,649,442 6.8% | 685,642![]() (+11.50%) | View |
2024-02-14 6:18 pm Sale | 13G | Benitec Biopharma Inc. BNTC | CITADEL ADVISORS LLC | 95,356 3.6% | -84,674![]() (-47.03%) | View |
2024-02-14 6:18 pm Sale | 13G | Clene Inc. CLNN | CITADEL ADVISORS LLC | 6,050,326 4.5% | -1,574,065![]() (-20.65%) | View |